Kaya Holdings (KAYS) Long-Term Investments (2020)

Kaya Holdings (KAYS) recorded quarterly Long-Term Investments of $31688.0 in Q4 2020.

Kaya Holdings (KAYS) Long-Term Investments (2020) Analysis & Trends

Kaya Holdings' Long-Term Investments history runs 1 years deep, the most recent figure standing at $31688.0 for Q4 2020.

  • In Q4 2020, Long-Term Investments changed N/A year-over-year to $31688.0; the TTM figure through Dec 2020 stood at $31688.0 (changed N/A YoY), while the FY2020 annual figure was $31688.0, changed N/A from the prior year.
  • Long-Term Investments was $31688.0 for Q4 2020 at Kaya Holdings.
  • In the past five years, Long-Term Investments ranged from a high of $31688.0 in Q4 2020 to a low of $31688.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.32 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.33 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 26.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.90 Mn
10 Kaya Holdings - - 5,370.00 -

Historic Data

Download Data
DateValue
Dec 31, 2020 31,688.00